Olema Pharmaceuticals develops targeted therapies for women's cancers, with a lead candidate in clinical trials for breast cancer treatment.
Including 1187.29 g/t silver over 14.8m and 21,833 g/t silver over 0.4m 358.15 g/t silver over 11.2 meters Including 662.03 g/t silver over 5.8m 7,330 g/t silver over 0.3m Hycroft Mining Holding Corp.